Raymond James & Associates’s SCYNEXIS SCYX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCYX
KCM
APM
AE
DADC
BCM
Raymond James & Associates's SCYX Position: Q3 2024 in Review
Raymond James & Associates sold out of SCYNEXIS (SCYX) in Q3 2024, closing a stake of 2,174 shares — an estimated $34.8K sold.
Raymond James & Associates first reported a position in SCYX in Q4 2019 and held it in 17 quarters. The position peaked at $104K in Q2 2021. 44 funds tracked by Wall St. Rank hold SCYX as of Q3 2024.
- Raymond James & Associates reported no remaining SCYNEXIS position as of Q3 2024 after selling out during the quarter.
- Raymond James & Associates sold 2,174 SCYNEXIS shares in Q3 2024, an estimated $34.8K.
- Raymond James & Associates first reported a position in SCYNEXIS in Q4 2019 and held it in 17 quarters.
- Raymond James & Associates's SCYNEXIS position peaked at $104K in Q2 2021.
- 44 funds tracked by Wall St. Rank held SCYNEXIS as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.